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STUDIES ON SERUM COPPER
I. THE COPPER CONTENT OF BLOOD SERUM IN PATIENTS WITH PSORIASIS*
GEORGE LIPKIN, M.D., FRANZ HERRMANN, M.D. AND LEONA MANDOL, B.A.
It has been established by a number of ana-
lytical and experimental observations that copper
plays an essential role in the normal keratiniza-
tion process of animal skin [1, 2, 3, 4].
Using histochemical technics to study the
structural development of wool fibers in sheep
fed on a copper deficient diet, Marston demon-
strated that the conversion of sulfhydryl groups
to disulfide linkages was both delayed and
diminished [3]. The total sulfur content of the
wool fibers was 10—15% below normal, and the
fibers were weakened, with loss of crimp. He
postulated a direct catalytic role of copper in the
oxidative closure of sulfhydryl residues to disul-
fide linkages.
Ellis et al. studied wool roots microchemically,
and demonstrated partial disappearance of copper
during the transformation of wool roots to mature
fibers [2]. Smith and Ellis described a copper
deficiency syndrome characterized by achromo-
triehia, alopecia, and scaly dermatosis in rabbits,
and they observed clearing of the dermatosis
upon dietary copper supplementation [4]. Burley
and DeKock, analyzing the N-terminal amino
acid residues of wool, found definite differences
between the terminal groups of wool from normal
and those of wool from copper deficient sheep
[1].
In human subjects, blood copper levels have
been assayed both under normal conditions and
in a large variety of pathological states, including
infectious, nutritional, metabolic, endocrine, and
neoplastic disorders. Several competent reviews
of the subject are available [5—12].
Only little attention, however, has been de-
voted in man to the copper "metabolism" in
cutaneous disorders, although those characterized
by aberrations in keratinization apparently
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would deserve such attention in great measure.
In this regard, the report by Findlay and Venter
is pertinent that serum copper levels are markedly
elevated in pellagra, a condition usually as-
sociated with inflammation and desquamation
of the skin [13]. Although absolute values were
not presented, the pellagrous subjects were
found to have serum levels up to double that of
the normal subjects investigated.
In view of the paucity of information about
blood copper levels in other scaly dermatoses, it
was thought to be of interest to find out whether
or not a significant difference exists between
serum copper levels of psoriatic patients and
those of non-psoriatic subjects. It is the object
of this presentation to report on assays conducted
along these lines.
A. Methods Available
METHOD
Quantitative assays of serum copper necessitate
the use of a highly sensitive procedure because of
the very low concentrations present. The diethyl
dithiocarbamate and dithizone reagents widely
utilized in previous eolorimetric assays are not
adequately sensitive. They are, moreover, not
sufficiently selective, as they react with other trace
metals as well, thus producing other colored com-
binations which call for intricate extraction pro-
cedures [141.
In the present study, therefore, the serum cop-
per levels were determined by the spectrophoto-
metric procedure of Peterson and Bollier 1141.
This method utilizes the tendency of his-
cyclohexanone-oxalyldihydrazone to combine with
copper and hereby to form a product of intensely
blue coloration. The sensitivity of this reagent has
been found superior to that of the previously used
substances, yet no disturbing color reaction was
observed with any of the other electrolytes com-
monly encountered in biological materials.
B. Further Elaboration of Procedure
Reagent Stability—In our efforts to ascertain
the stability of the solutions employed in order to
carry out the reactions under strictly comparable
conditions, it was found that the standard refer-
ence solutions of copper had undergone decom-
position after two weeks of storage at room tem-
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perature, and somewhat later at refrigerator
temperatures.
When the reagent solution was added to aqueous
serial dilutions of a stock solution of euprie sulfate
which had been prepared two or more weeks be-
fore, the speetrophotometrie transmission
readings obtained were too high. The correspond-
ing Cu readings amounted to only 90% to 98% of
the Cu readings obtained with the freshly prepared
copper solution and its dilutions.
It became evident, therefore, that fresh stand-
ard solutions of euprie sulfate must be prepared
at intervals of ten days to [not more than] two
weeks, and stored under refrigeration. Observing
these new precautions, two investigators, in in-
dependent "blind" determinations of the copper
concentration in prepared solutions or in different
specimens of blood serum, obtained values which
differed by 5% or less from each other.
Specimen Stability—All serum specimens were
obtained by separation from freshly clotted blood.
Thereafter, the copper values remained equal up
to two weeks for any given specimen stored at
refrigerator temperatures.
SUBJECTS
Serum copper values were assayed in 26 healthy
subjects, 14 white males, 23 to 45 years of age—and
in 12 white females, 23 toSS years of age.
TABLE I
Copper concentration in blood serum*
Groups Sex
Number
of Sub-jects
Mean Serum
Copper in
MCG/ML
Range
Healthy Con-
trolSubjeets
M
F
14
12
1.58
1.69 1 .00—2.73
Psoriatic
subjects
M
F
20
9
2.02
2.02
0.63—2.96
*We wish to thank Mrs. Lee F. Herrera, De-
partment of Medical Statistics, New York Uni-
versity Medical Center, for advising us in the
statistical analysis and presentation of the re-
sults obtained.
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In addition, the serum analyses were performed
in 29 outpatients with typical psoriasis. Twenty
of these patients were white males, 28 to 69 years
old. The remaining nine patients were white fe-
males, 13 to 60 years old. The duration, extent, and
activity of the eruptions varied widely among the
subjects.
At the time of the first blood collection, some of
the patients had been receiving external treatment
with medications other than those containing
steroid, but none had received any systemic-,
radiation-, or heliotherapy within the preceding
three months.
RESULTS
The findings obtained in our healthy control
subjects and in the psoriatic patients are listed
on Table I. The mean value of serum copper
found in healthy subj ects averaged below the
value found in the subjects affected by psoriasis.
This difference has been significant statistically
for the males [0.01 < P < 0.02], but failed to
reach significance in the smaller groups of females
[0.2 < P < 0.3]. Apparently, there was no sex
difference between our values obtained in either
psoriatic or healthy subjects.
When the subdivision according to sex is dis-
regarded, the difference between the results
obtained in all our psoriatics and those obtained
in all of the control subjects would actually be
significant [P < 0.01]. A considerable overlap,
however, is apparent in the serum copper levels
of normals and psoriatics, with some of the lowest
values found in psoriatic subjects, and some of
the highest values in healthy subjects [see graph].
DISCUSSION
Our finding of elevated serum copper levels in
psoriatics requires further investigation before
definite conclusions can be drawn.
It will be of crucial importance to exclude all
subjects from the investigation who show pecu-
liarities or pathological conditions known to be
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GRAPH I. Distribution of serum copper values in healthy subjects and in psoriaties
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possibly associated with elevation or depression
of blood copper. Elevation has been observed
in a variety of states, including the last trimester
of pregnancy, hyperthyroidism, Addison's dis-
ease, certain hypochromic anemias, pernicious
anemia, aplastic anemia, leukemias, lymphomas,
carcinoma, various subacute and chronic infec-
tions, and certain hepatic diseases [5, 6, 7, 8,
10, 11]. Inflammatory and febrile states in general
apparently tend to show some elevation in blood
copper, and this tendency might have a bearing
on our present observation.
Decrease in blood copper has been recorded in
some cases of Wilson's disease, severe nephritis
with hypoalbuminemia, acute leukemias treated
with ACTH, and hypothyroidism [8, 9].
To the best of our knowledge, none of the pa-
tients and control subjects included in our present
study was afflicted by any of those conditions.
Whereas Lahey et at. did not observe any con-
siderable diurnal, daily, or weekly fluctuations
in the plasma copper level, or any such fluctua-
tions with regard to intake of food or to menstrua-
tion, these authors did note significantly higher
plasma copper levels in females than in males.
This sex difference was not apparent in the
present group [7, 8] either among normals or
psoriatics. Should the difference by chance have
been obscured in our relatively small number of
[healthy] persons, the predominance of males over
females in the psoriatic group would, with some
probability, have resulted in a lower serum copper
among the psoriatics than among the non-psoria-
tics, whereas the reverse was actually found.
To our knowledge, no aberration in serum
copper levels has been reported thus far in psoria-
sis. Whether the finding observed by us is due
to inability of the epidermal cells to utilize copper
in the formation of keratin, or whether the excess
copper is derived from some other source, remains
to be studied. Of relevance to the question is the
report of MacCardle et at. of elevated tissue
copper levels in psoriatic skin on spectrographic
analysis [15]. It would be of interest to extend
such tissue analyses to other scaly dermatoses.
It furthermore would be of interest to find out
to what extent hypercupremia is encountered
also in other dermatoses associated with para-
keratosis. It would appear to be more likely that
the elevation in serum copper somehow is second-
ary to the imperfect keratinization, rather than
a causative factor.
sUMMARY AND CONC LU5ION5
1. Serum copper values were assayed spectro-
photometrically in 29 psoriatic- and 26 healthy
control subjects.
2. The method by Peterson and Bollier was
used in these assays; but it was found that the
standard reference solutions of copper must be
prepared at least every two weeks.
3. Despite considerable overlap in copper values
between the two groups, the copper levels were
significantly higher in the patients with psoriasis
than in the control subjects.
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DISCUSSION
DR. PETER FLESCR, Philadelphia, Pa.: Al-
though with Dr. Rothman we are among the
people who developed the idea of the role of
copper in kcratinization, I would like to em-
phasize that this is proved in the case of wool
only. Copper may have nothing to do with epi-
dermal keratinization. There is also an over-
lapping of the copper values and I wonder how
valid the statistical analyses are.
DR. GEORGE LIPKIN, (in closing): I would like
to thank Dr. Flesch for his comments. We are
aware of the pitfalls inherent in transfei ring to
human epidermis findings obtained in animal
species, particularly with hair keratins. Never-
theless, we feel the subject merits investigation.
Our statistical methods were standard ones,
and adequate for the study.
Subsequent to submission of this paper some
additional work has been done, which was omitted
for the sake of brevity. First, in cooperation with
Dr. Beam of the Rockefeller Institute, the serum
ceruloplasmin levels were determined in six
psoriatic patients. Mild elevation was present
in four of the six, but the number of subjects
was too small for statistical significance. Since
about ninety-five percent of serum copper is
bound to ceruloplasmin, one might expect any
tendency toward serum copper elevation to be
reflected in this fraction.
Tissue copper was also determined in involved
skin of twelve psoriatics, and in contradiction
to an earlier report of elevation (Mac Cardle,
R. C., Engman, M. F., Jr., and Engman, M. F.,
Arch. Dermat. and Syph. 44: 429 (Sept. 1941)),
was within the normal range. One cannot, how-
ever, rule out the presence of some more subtle
enzymatic abnormality in copper metabolism,
despite absence of any gross quantitative altera-
tion.
Several interesting recent findings concerning
copper metabolism might be briefly mentioned.
It has been shown that copper is capable of
augmenting the catalytic oxidation of glutathione
by sulfhydryl oxidase (Ames, S. R., and Elvehem,
C. A., J. Biol. Chem. 159: 549, 1945; Rony,
H. H., Scheff, G. J., Cohen, D. M., and Rennagel,
W. R., J. I. D. 30: 43, 1958). In England, Gal-
lagher and coworkers have demonstrated that
copper is essential for normal phospholipid syn-
thesis in rat liver mitochondria (Gallagher, C. H.,
Judah, J. D., and Rees, K. R., Proc. of Royal
Soc.—Series B—145: 1956, pp. 195—205).
Whether these findings have any relevance to
the problem of psoriasis remains to be determined.
